chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in arm; sense of taste lost; blurry vision; Fever; shaking; nausea; my bones hurt; I was tired; headache; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), AGEUSIA (sense of taste lost), VISION BLURRED (blurry vision), PYREXIA (Fever) and TREMOR (shaking) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seizures and Migraine. Concomitant products included RIZATRIPTAN BENZOATE (MAXALT) for Migraine, ESLICARBAZEPINE ACETATE (APTIOM) for Seizures, PANTOPRAZOLE SODIUM SESQUIHYDRATE (PANTOPRAZOLE 40) and TIZANIDINE for an unknown indication, FLUOXETINE HYDROCHLORIDE (PROZAC).   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in arm), AGEUSIA (sense of taste lost), VISION BLURRED (blurry vision), PYREXIA (Fever), TREMOR (shaking), NAUSEA (nausea), RESORPTION BONE INCREASED (my bones hurt), FATIGUE (I was tired) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (Pain in arm), AGEUSIA (sense of taste lost), VISION BLURRED (blurry vision), PYREXIA (Fever), TREMOR (shaking), NAUSEA (nausea), RESORPTION BONE INCREASED (my bones hurt), FATIGUE (I was tired) and HEADACHE (headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient returned to the pharmacy with a rash that had gone down to his elbow. It was red, feverish, and swollen. Patient states he has had a fever on and off since receiving the vaccines.
Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/4/2022 Discharge Date: Dec 16, 2022 COVID positive date: 12/4/2022 PRESENTING PROBLEM: Acute respiratory failure with hypoxia [J96.01] COVID-19 infection Ground-glass opacity secondary to COVID-19 COPD     HOSPITAL COURSE: 58 y/o male with hx of COPD,who was admitted for acute hypoxic respiratory failure 2/2 COVID pneumonia.  He has completed 10 day course of decadron.  He was not given remdesivir given length of time since onset of symptoms.     Initially patient required 5L O2 via Nc, but were able to titrate down to 2 L of oxygen at all times.   Patient is homeless and stays at shelter and was discharged in stable condition.   He will continue to follow-up with PCP and counseled about tobacco cessation
ADMINISTERED TO A 14 YEAR OLD PATIENT; A spontaneous report () was received from a healthcare professional concerning a 14-years old patient of unknown gender, who received two doses of Moderna's covid-19 vaccine (mRNA -1273).  The patient's medical history was not provided. Concomitant medications were not reported.  On 25 FEB 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 004M20A) via unknown route for prophylaxis of COVID-19 infection.  On 25 FEB 2021, the patient received vaccine at an age of 14 and no other events were reported. No treatment was taken.  Action taken with mRNA-1273 in response to the event was unknown.  At the time of this report, the outcome of the event vaccination at an inappropriate age was unknown.; Reporter's Comments: This case concerns a 14-year-old patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.
Severe chills/shivering for about an hour. Fatigues, slight fever, body aches for about 24 hours, beginning about 12 hours after shot.  Chills and fever were mostly resolved by a dose acetaminophen.
Patient received a 2nd dose 30 days after the first dose; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included lymphoma (was in remission of lymphoma). Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 25-APR-2022 Reporter's Comment: The reporter reported that, due to a miscommunication, a patient received a second dose of Shingrix 30 days after the first dose instead of 60 days. The reporter consented to follow up. Additional Supportive Information: The patient received a second dose of Shingrix earlier, which led to shortening of vaccination schedule.
On December 3rd, my family physician, during a routine visit to receive the flu vaccine told me I needed a tetnus booster to which I agreed.  Approximately one and one half weeks later I woke up in the morning with every single solitary joint in my body stiff and aching right down to the joints in my toes.   I contacted Dr. and was told that those symptoms were not typical of the tetanus shot.  I disagree with his findings.  This arthritis and pain and stiffness of all of my joints began on or about December 14th and still persisits.  I am awakened many times during the night due to it.  It is difficult for me to get up after sitting down or driving for 15 mintues or so.  Now, two nights ago on December 21 I experience very deep aching pain in my right leg all night.  I am also experiencing sharp pains often in various parts of my body.
Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Additional Details: Patient reported feeling that he was going to faint, had anxiety, and was sweating.  Rescue called and he was evaluated. All vitals ok and patient recovered.  He left with his father.
Patient did not experience any adverse reaction to the vaccine.  It was later discovered that patient previously went to an off site pharmacy on 2/09/2023 to receive an MMR vaccine and the Varicella vaccine should not have been administered on 2/22/2023, instead Varicella should of been administered 30 days after MMR vaccine. Patient feels fine no side effects, did not report to nurse that she had received MMR (live) vaccine prior to requesting for Varicella vaccine.
Information has been received from a registered nurse concerning a 22 year old female who on 15-OCT-2007, was vaccinated with a dose of Gardasil (possible lot#'s 0523U, 1425F, 0515U) that was improperly stored reaching 32 degrees F on 4 occasions 10/02/2007, 10/03/2007, 10/09/2007 and 10/11/2007.  No problems were reported.  It was unknown whether medical attention was sought.  There was no product quality complaint.  This is one of several reports from the same source.
Experienced nasal passage swelling, Sort of like congestion but dry, shortness of breath caused by this.
Arm in a lot of pain; Can't lift the arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm in a lot of pain) and MOBILITY DECREASED (Can't lift the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm in a lot of pain) and MOBILITY DECREASED (Can't lift the arm). At the time of the report, PAIN IN EXTREMITY (Arm in a lot of pain) and MOBILITY DECREASED (Can't lift the arm) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Pericarditis, plural effusion, cardiac tamponade, heart failure, pneumonia.
she is getting a hard chill and fever; she is getting a hard chill and fever / Highest temperature she had was 101.7; Her arm was red and puffy; the fluid in a little puff in my arm. It just stayed there; She's not hungry; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 26Sep2023 as dose number unknown (booster), single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 Immunization, reaction(s): "she is getting a hard chill and fever"; Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization, reaction(s): "she is getting a hard chill and fever"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization, reaction(s): "she is getting a hard chill and fever", "she is getting a hard chill and fever". The following information was reported: CHILLS (non-serious), outcome "unknown", described as "she is getting a hard chill and fever"; PYREXIA (non-serious), outcome "unknown", described as "she is getting a hard chill and fever / Highest temperature she had was 101.7"; ERYTHEMA (non-serious), PERIPHERAL SWELLING (non-serious), outcome "unknown" and all described as "Her arm was red and puffy"; DECREASED APPETITE (non-serious), outcome "unknown", described as "She's not hungry". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient confirms the Pfizer Comirnaty 2023/2024 vaccine for adults is the product she received. She wanted to know if the chills and fever are normal because all her Covid shots have been from Pfizer and it always happens. She got a hard chill the previous night that lasted about 2-3 hours and that day she is just "washed out." She's not hungry but is trying to drink fluids. She thinks he (the vaccine administrator) "got it in the wrong place" in her arm and "that's what took time for the fluid". She said usually that's never happened before, and that "everyone I've ever taken" (as reported) is gone within 12 hours. The same thing happens. He put in the wrong place in my arm. It's happened before. Like in the muscle and it didn't dissolve, it stayed there, and you could see the fluid in a little puff in my arm. It just stayed there." The patient also added that, compared to another lady she knows, she is the only one who gets these side effects. The lady she knows didn't get any side effects.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
not feeling good; Diarrhea; Feels sore; shortness of breath; he isn't feeling well; This is a spontaneous report from a Pfizer sponsored program Support. A contactable male consumer (patient) reported that. A male patient of an unspecified age received bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: was not reported) dose 1 via an unspecified route of administration on unspecified date in Aug2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 29Aug2021 the patient experienced shortness of breath, diarrhea and feels sore. On 30Aug2021 the patient experienced not feeling good. On an unspecified date in Aug2021 patient experienced he isn't feeling well. Consumer was supposed to take his 2nd dose of the Pfizer COVID 19 vaccine today and he is not feeling good. States he is asking for advice on when to take the 2nd dose. The outcome of the events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be re-quested during follow up.  Follow-up activities closed. Batch /lot number not available.
nausea; vomiting; headache; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore left arm). On 16-Apr-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) (oral) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore left arm), NAUSEA (nausea), VOMITING (vomiting) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Patient reports onset of headache and blurred vision within 24 hours of vaccination. States she waited two weeks to see her eye specialist and at that time she was told her eyeglasses prescription had changed from her appointment three months prior.
Redness (local); itching; large red area around vaccine site. Patient says same reaction happened last year when got flu shot at MD office.
Has felt like a Tetnus shot reaction since the day after. When the pharmacist shot into arm, I felt it in my muscle. I am unable to get dressed and lift heavy things without pain.
seizure; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received first dose of BNT162B2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced seizure on an unspecified date. Outcome of the event was unknown.
Cough worsen 10-26-09 at 8:30.  On 10-27-09 noted temp 101.6, body aches, bilateral ear popping at 7:00 am.  Pt seen by Dr. this am and ordered Tamiflu and Phenergan.
Vaccine was not diluted. Patient received 0.3 milliliters of undiluted BioNTech solution.
Case number PHEH2014US022419 is an initial spontaneous report received from a physician on 06 Nov 2014. This report refers to a male patient whose age was not reported. His medical history and concomitant medications were not reported. He was vaccinated with FLUVIRIN (batch number: 1412901) intramuscularly in arm on 01 Oct 2014. It was reported that he was experiencing pain in his arm and shoulder of injection site since he was administered the injection. He had pain only when moving around and not pain at rest. The events outcome was unknown. The seriousness and causality of the event was not reported.
Muscle spasms (at site of inj,+ foot, thigh, facial) painful muscle at injection site(still at day 6)lg area redness below inj site still, arm swollen resolved day 6, at 24 hrs from inj fever 101 w/Tylenol on board, then 99 to 100 degree after day 3 resolved day 6.
104.0 Temp began within hours of vaccine. Motrin and Tylenol gives every 3 hours rotating for 3 days.
Post vax the patient experienced a fever and swelling of the right leg from the injection site to the ankle, and also redness and the development of blisters on that leg. The patient was seen at the ER. Doctors at ER were concerned about possible bug bite.
Patient reported itching to site post vaccination. Onset of 10 minutes post vaccine.  Noted spreading urticaria to left arm adjacent to site of administration. Patient denies airway involvement. No respiratory distress noted, patient speaking in full sentences.  VS as follow  BP 132/74 HR 77 Oxygen saturation 95% on RA  16 RR.   MD Stat called.  Dr. and RN responded to assess patient.  After assessment MD decided to take patient to clinic.  Patient ambulated out of the vaccine clinic with a strong and steady gait.
Left arm with large red raised lesion measuring approximately 11 cm x 12 cm. Tender, itchy. Has tried Benadryl cream with relief, Tylenol for tenderness.
Swelling, itching, redness. TYLENOL prn, cold compress, cortisone cream.
flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced heavy flu like symptoms after 1st dose of Shingrix. This case linked with US2019AMR119306, reported by same reporter.
Patient developed a hard, raised area that was sore to touch. The area was very dry and 2 inches in diameter.
I had muscle spasms that caused sharp pain in my upper right back radiating down into my right arm. I was prescribed cyclobenzaprine and prednisone.
Pain during injection-initially dull pain as vaccine was dispensed followed by VERY sharp pain until needle was withdrawn.  Sometime during the next few hours a golf-ball size red area with a clearly defined border appeared, and a knot developed at the injection site.   It was only painful when I touched the area.  I took some acetaminophen.  The following day the red area had doubled in diameter (still with a defined border)and the painful knot was still present.   Other symptoms this day included fatigue and chills.  I took more acetaminophen. The third day (today) the red area appears the same size but with blurry edges and the area is a little less painful.
dose number=3; insomnia; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 20 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 20 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Dose brand=Pfizer, Batch/Lot No: 73529), when the patient was 20 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Dose brand=Pfizer, Batch/Lot No: 73529), when the patient was 20 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "dose number=3"; INSOMNIA (non-serious), outcome "unknown", described as "insomnia".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within 30 hours post vax, the pt began to develop whelps which progressed to generalized urticaria.
after taking Pfizer  vaccination I began to feel like I had covid all over again.; after taking Pfizer  vaccination I began to feel like I had covid all over again.; Body pain; chills; headaches; fatigue; This is a spontaneous report from a contactable consumer. A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 02Mar2021 (at the age of 59-years-old) (Batch/Lot Number: EL9266), dose 1 via an unspecified route of administration, administered in Arm Right on 28Jan2021 12:00(also reported as 28Feb2021, pending clarification) (lot number:EN5318); both as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 02Mar2021 07:00, after taking Pfizer vaccination the patient began to feel like he had covid all over again. Body pain, chills, headaches, fatigue. The patient tested positive on 27Dec2020. The patient did not receive treatment for the events. The patient was not tested for COVID post vaccination. The patient underwent lab tests and procedures which included covid-19: positive on 27Dec2020. The outcome of the events was not recovered.   No follow-up attempts possible. No further information expected. Batch/lot number already provided
PNEUMOVAX given 11-11-13 in left arm. Arm slightly sore initial 5 days. On 6th day pain increased to severe and extended into elbow. If pt. holds arm still he has no pain, but with certain movements. Pain is severe.
No additional AE; Two doses of MMR II administered after a prior temperature excursion; route: IM; Information has been received from a nurse, referring to a 4 years old male patient.  Information about concurrent condition, concomitant medication and medical history was not provided.    On 31-MAR-2022, the patient was vaccinated with the first dose of temperature excursion measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # T039671 (therapy type rHA), expiration date on 24-NOV-2022) intramuscularly for prophylaxis (incorrect route of product administration and product storage error). No adverse effects were reported.   The measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was entered with freezer temperature/time instead of the refrigerated temperature/time. The vaccines had a temperature prior of 10.4 Celsius degree for 3 hours and 30 minutes; current of 8.6 Celsius degree of 1 hour 1 minute.  This is one of two reports received from the same reporter.
1. pain in rt arm, unable to use for 3 days 2. shivers (body wrapped in clothing, jacket, bath robe and blanket), unable to control shivers. felt very cold 3. temperature up to 102, fluctuated overnight 4. nausea, unable to eat for 5 days (included diarrhea) lost 10 lbs. in 5 days 5. headache  The shivers, temp fluctuation lasted only 24 hours. The arm pain lasted for 3 days. The nausea lasted 5days. I did not contact my doctor nor did I seek treatment the reactions were gone 5-6 days later. I haven't felt this bad for years, but I'll have to say it was over in less than a week, but I'm very wary of taking the second shot.
-HIVES ON ABDOMINAL AREA AS WELL AS ON BOTH THIGHS. -PATIENT ALERT AND PLAYFUL ALL THIS TIME. -NO RESPIRATORY DISTRESS. -GIVEN ZYRTEC (CETIRIZINE) 2.5mg po, syrup, STAT.
Pt described appearance of blisters in his mouth approx. 1 week after vaccine and feeling lethargic.
pt reported numbness, weaknees in arms, extreme fatigue, slight shortness of breath above baselines.